News & Blog

Innovating Brain Tumor Clinical Trials: Lessons Learned During the COVID-19 Experience

The global COVID-19 pandemic disrupted nearly every facet of life in 2020, and brain cancer research, particularly clinical trials, was not spared from its impacts. As is often the case, though, with disruption comes the opportunity to innovate. Convening key stakeholders across the brain tumor community, the National Brain Tumor Society (NBTS) has taken stock […]

New Treatment Arms Opening for Patients in NBTS-Funded GBM AGILE Clinical Trial

Yesterday, it was announced that the GBM AGILE adaptive clinical trial platform is opening two new treatment arms, with one evaluating Kintara Therapeutics’s chemotherapy, VAL-083, and Kazia Therapeutics’s targeted therapy, paxalisib.  “NBTS has long supported GBM AGILE as a scientifically cutting-edge and more patient-friendly way to develop and evaluate emerging new treatments for patients,” says […]

Sights & Sounds: Glioblastoma Awareness Day (#GBMDay) 2020

Perhaps Dr. Ned Sharpless, Director of the National Cancer Institute, summed up Glioblastoma (GBM) Awareness Day 2020 best when he said during NBTS’s Defeating GBM: A Virtual Town Hall event, “Events like this are really important to re-energize the community so we can join together and make progress in a disease that where progress has been […]

Share